B9C-25017-83695
2 vaccinations
1 coded response
14 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 972 / OR
- Registered
- 2021-03-27
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-27
Registered in v-safe
-
2021-03-27
Dose 1 — Pfizer-BioNTech
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-04-05
- 2021-04-10
- 2021-04-17
-
2021-04-25
Dose 2 — Pfizer-BioNTech
- 2021-04-25
-
2021-04-26
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-27
Survey response — days 1–6 daily, dose 2MedDRA: Fatigue, Morning sickness, Pregnancy — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: Pregnancy fatigue/morning sicknessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-28
- 2021-04-29
- 2021-04-30
- 2021-07-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-27 | Pfizer-BioNTech | |
| 2 | 2021-04-25 | Pfizer-BioNTech |
Free text
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Pregnancy fatigue/morning sickness
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Morning sickness | ✓ | ✓ | ✓ |
| SRO | Pregnancy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release